TNF and rheumatoid arthritis: TNF-α inhibitors suppress nuclear factor-kappaB (NF-кB) activity (28), but one study showed that adalimumab therapy was not effective on the NF-кB activity of lymphocytes in patients with rheumatoid arthritis (29).